IntelGenx Technologies Corp. (IGXT) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
6420 ABRAMS SAINT LAURENT, QC H4S 1Y2 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 4,748 | 6,977 | 10,249 | 9,949 | 12,032 | 12,129 | 2,384 | ||
| Cash and cash equivalents | 1,498 | 1,975 | 6,614 | 3,945 | 6,019 | 6,121 | 1,978 | ||
| Short-term investments | 3,250 | 5,002 | 3,635 | 6,004 | 6,013 | 6,008 | 406 | ||
| Receivables | 589 | 588 | 754 | 680 | 1,162 | 518 | 376 | ||
| Inventory, net of allowances, customer advances and progress billings | 80 | 85 | 88 | 62 | 68 | 121 | 120 | ||
| Inventory | 80 | 85 | 88 | 62 | 68 | 121 | 120 | ||
| Prepaid expense | 112 | 120 | 132 | 105 | 116 | 79 | 166 | ||
| Deposits current assets | 189 | 201 | 208 | 205 | 204 | 210 | 206 | ||
| Other undisclosed current assets | 93 | 219 | 225 | 436 | 407 | 781 | 301 | ||
| Total current assets: | 5,811 | 8,190 | 11,656 | 11,437 | 13,989 | 13,838 | 3,553 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 774 | 878 | 961 | 1,003 | 1,050 | 668 | 689 | ||
| Property, plant and equipment | 4,527 | 4,864 | 5,163 | 5,213 | 5,348 | 5,651 | 5,748 | ||
| Deposits noncurrent assets | 242 | 257 | 256 | 252 | 252 | 259 | 255 | ||
| Total noncurrent assets: | 5,543 | 5,999 | 6,380 | 6,468 | 6,650 | 6,578 | 6,692 | ||
| TOTAL ASSETS: | 11,354 | 14,189 | 18,036 | 17,905 | 20,639 | 20,416 | 10,245 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,974 | 1,978 | 2,351 | 2,299 | 2,304 | 2,182 | 1,949 | ||
| Other undisclosed accounts payable and accrued liabilities | 1,974 | 1,978 | 2,351 | 2,299 | 2,304 | 2,182 | 1,949 | ||
| Deferred revenue | 138 | 189 | 192 | 134 | 145 | ||||
| Debt | 35 | 37 | 4,364 | 4,283 | 5,352 | 2,527 | 3,579 | ||
| Other undisclosed current liabilities | 231 | 245 | 252 | 249 | 248 | 148 | 144 | ||
| Total current liabilities: | 2,240 | 2,260 | 7,105 | 7,020 | 8,096 | 4,991 | 5,817 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 6,016 | 6,103 | 6,179 | 3,226 | 3,283 | 8,585 | 7,469 | ||
| Long-term debt, excluding current maturities | 5,500 | 5,500 | 5,500 | 2,500 | 2,500 | 8,068 | 6,928 | ||
| Finance lease, liability | 51 | 63 | 75 | 84 | 92 | 72 | 78 | ||
| Operating lease, liability | 465 | 540 | 604 | 642 | 691 | 445 | 463 | ||
| Liabilities, other than long-term debt | 79 | 82 | |||||||
| Deferred income tax liabilities | 79 | 82 | |||||||
| Other undisclosed noncurrent liabilities | 3,761 | 3,641 | 3,534 | 3,709 | 3,965 | (445) | (463) | ||
| Total noncurrent liabilities: | 10,242 | 10,284 | 10,317 | 7,014 | 7,330 | 8,585 | 7,469 | ||
| Total liabilities: | 12,482 | 12,544 | 17,422 | 14,034 | 15,426 | 13,576 | 13,286 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | (1,128) | 1,645 | 614 | 3,871 | 5,213 | 6,840 | (3,041) | ||
| Common stock | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Additional paid in capital | 67,321 | 67,119 | 62,842 | 63,104 | 61,589 | 61,043 | 48,662 | ||
| Accumulated other comprehensive loss | (2,664) | (2,365) | (1,703) | (1,371) | (1,372) | (1,201) | (892) | ||
| Accumulated deficit | (65,786) | (63,110) | (60,526) | (57,863) | (55,005) | (53,003) | (50,812) | ||
| Total stockholders' equity: | (1,128) | 1,645 | 614 | 3,871 | 5,213 | 6,840 | (3,041) | ||
| TOTAL LIABILITIES AND EQUITY: | 11,354 | 14,189 | 18,036 | 17,905 | 20,639 | 20,416 | 10,245 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 142 | 398 | 237 | 494 | 593 | 162 | 286 | |
| Cost of revenue | (429) | (482) | (470) | (658) | (499) | (478) | (10) | |
| Cost of goods and services sold | (429) | (482) | (470) | (658) | (499) | (478) | ||
| Financing interest expense | (10) | |||||||
| Gross profit: | (287) | (84) | (233) | (164) | 94 | (316) | 276 | |
| Operating expenses | (2,533) | (2,582) | (2,547) | (3,001) | (2,234) | (2,069) | (2,213) | |
| Other undisclosed operating income | 429 | 482 | 470 | 658 | 499 | 478 | 10 | |
| Operating loss: | (2,391) | (2,184) | (2,310) | (2,507) | (1,641) | (1,907) | (1,927) | |
| Nonoperating expense | (285) | (400) | (376) | (354) | (364) | (284) | (334) | |
| Investment income, nonoperating | 1 | 1 | 1 | 151 | ||||
| Interest and debt expense | (286) | (400) | (75) | (365) | 151 | (75) | ||
| Loss from continuing operations before equity method investments, income taxes: | (2,962) | (2,984) | (2,761) | (2,861) | (2,370) | (2,040) | (2,336) | |
| Other undisclosed income from continuing operations before income taxes | 286 | 365 | ||||||
| Loss from continuing operations before income taxes: | (2,676) | (2,984) | (2,761) | (2,861) | (2,005) | (2,040) | (2,336) | |
| Income tax benefit | 3 | 3 | ||||||
| Net loss: | (2,676) | (2,984) | (2,761) | (2,858) | (2,002) | (2,040) | (2,336) | |
| Other undisclosed net income (loss) attributable to parent | 400 | 75 | (151) | 75 | ||||
| Net loss available to common stockholders, basic: | (2,676) | (2,584) | (2,686) | (2,858) | (2,002) | (2,191) | (2,261) | |
| Interest on convertible debt | 87 | 119 | 115 | |||||
| Net loss available to common stockholders, diluted: | (2,676) | (2,584) | (2,599) | (2,739) | (2,002) | (2,191) | (2,146) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | 12/31/2021 Q4 | 9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (2,676) | (2,984) | (2,761) | (2,858) | (2,002) | (2,040) | (2,336) | |
| Comprehensive loss: | (2,676) | (2,984) | (2,761) | (2,858) | (2,002) | (2,040) | (2,336) | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (299) | (262) | (257) | 1 | (171) | (460) | 39 | |
| Comprehensive loss, net of tax, attributable to parent: | (2,975) | (3,246) | (3,018) | (2,857) | (2,173) | (2,500) | (2,297) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.